Thermo Fisher Scientific Acquires Programmable Dye Platform Pioneer Phitonex
News provided by
Share this article
Share this article
WALTHAM, Mass., Dec. 31, 2020 /PRNewswire/ Thermo Fisher Scientific, the world leader in serving science, today announced it has completed the acquisition of Phitonex, Inc., a Durham, North Carolina-based company that has pioneered a spectral dye platform for high-resolution biology applications designed to accelerate research and development in cell therapy, immuno-oncology and immunology research. Phitonex s product offering will enable Thermo Fisher to offer greater flow cytometry and imaging multiplexing capabilities to meet evolving customer needs in protein and cell analysis research.
The innovative platform, called the Phiton, acts as a structure that can maintain a higher number of fluorescent dyes in very specific ways, allowing researchers the ability to analyze single cells in high resolution. Consequently, it enables researchers to a
Thermo Fisher Adds Phitonex
Thermo Fisher Scientific has acquired
Phitonex Inc. Phitonex manufactures medical research materials.
Phitonex’s technology, Phiton, is useful for biological and healthcare research with cells. “Phitonex’s platform is a natural extension of Thermo Fisher’s existing tools for protein and cell analysis applications,” says Thermo Fisher senior vice president
Peter Silvester. “Combining this new technology with our existing portfolio and expertise in this space will unlock the Phiton platform’s great potential and deliver unparalleled flow cytometry performance so our customers can gain more valuable insights from a single cell and expedite discovery.”
Thermo Fisher provides scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories in academia, government, and industry.